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This article highlights the increasing importance of Maedi Visna (MV) within the national flock. MV is 
considered to be one of the ‘Iceberg Diseases;’ a group of infectious, production-limiting diseases 
which are endemic to the UK. Characterised by slow, progressive onset these diseases lie undetected 
and can have a large impact on flock efficiency. They also include Border Disease, Caseous 
Lymphadenitis, Ovine Johnes Disease and Ovine Pulmonary Adenocarcinoma. The prevalence and 
effects of these diseases within different UK flock types remains unknown.  
 
Abstract 
Maedi visna (MV) is an infectious, insidious production limiting disease of sheep. MV leads to a 
progressive loss of condition, reduced flock production and poor economic performance. The 
prevalence within the UK sheep flock appears to be rising. MV is transmitted between sheep and 
goats; once infected animals become lifelong carriers. The immune response may take up to several 
months, and the incubation period for the disease may take several years. Clinical cases may only 
become obvious when a significant proportion of the flock are infected; however subclinical signs 
appear well before this. The disease is incurable and progressive, but several control options are 
suggested.  
 
What is Maedi Visna?  
 
Maedi visna (MV) is a highly infectious disease of sheep caused by a non-oncogenic retrovirus, maedi 
visna virus (Figure 1) (Radostits et al., 2007). It has a long incubation period ranging from several 





productivity and poor economic performance (Ritchie, Davies and Smith, 2012). Infected sheep will 
produce antibodies, however they are unable to eliminate the virus and so become life-long carriers 
of the disease (Ritchie, Davies and Smith, 2012). There is no treatment or cure for the disease and 
due to the nature of the disease there appears to be little chance of development of an effective 
vaccine.  
 
Why is it important now?  
 
MV appears to be widely dispersed in the UK flock. A study funded by the Agricultural and 
Horticultural Development Board and conducted by the Scottish Agricultural College (SAC) and 
Animal Health and Veterinary Laboratories Agency (AHVLA, now Animal and Plant Health Agency) 
(2012) using a random sample of UK flocks found that the prevalence of infected flocks appeared to 
have doubled between 1995/6 and 2010 (1.4% to 2.8%, p=0.015). Although the between flock 
prevalence appears to be relatively low, the rate of increase is alarming; some UK flocks have found 
the within flock prevalence to reach 85% (Ritchie, Davies and Smith, 2012; Priestley, 2016). Six years 
ago it was estimated that 100,000 ewes within the national flock could be infected with MVV 
(Ritchie, Davies and Smith, 2012) and the rate of increase is likely to be exponential. The apparent 
Figure 1: Key facts relating to small ruminant lentiviruses (SRLVs):  
  
• Maedi visna virus (MVV) is closely related to caprine arthritis encephalitis virus (CAEV). 
• MVV and CAEV are a small ruminant lentiviruses (SRLVs) from the Retroviridae family 
(Iratxe Leginagoikoa et al., 2006), and both may be transmitted between both species.  
• SRLVs lead to slow, progressive and fatal lymphoproliferative disease (Berriatua et al., 
2003). 
• Cases of MVV and CAEV infection present differently. Sheep infected with MVV primarily 
show respiratory signs and lose condition. They may also be affected by mastitis and show 
progressive neurological sings. Goats infected with CAEV commonly present with a 
polysynovitis-arthritis. Goats may also suffer with a loss of condition; poor hair-coat; 
respiratory signs and mastitis.  
• The Lentivirus genus also contains human immunodeficiency virus (HIV), feline 
immunodeficiency virus (FIV), bovine immunodeficiency virus (BIV) and equine infectious 






increasing prevalence of MV within the UK means that understanding the effect of the disease are 
increasingly relevant.     
 
How does MV impact on flock production? 
 
Only partial data on productivity 
losses associated with MV 
infection are available for UK 
flocks at present. The financial 
costs may be influenced by several 
factors (Figure 2). In flocks with 
clinical MV, the within flock 
prevalence is often identified 
between 20 and 60%. A lag period 
of several years appears to be seen from initial flock infection to diagnosis due to clinical signs or 
production issues; this is a classic characteristic of an iceberg disease.   
 
Some of the production effects and associated financial implications of MV infection within a flock 
have been calculated (Table 1). Although these figures may not be representative of all flocks or 
systems, it goes some way to identify the potential economic losses associated with prolonged MVV 
infection within a flock. Further studies are needed to quantify additional effects of subclinical 
disease such as on-going transmission within infected flocks and how this relates to different flock 
types and management systems where transmission dynamics differ (I. Leginagoikoa et al., 2006).
Figure 2: Factors influencing financial costs associated 
with MVV infection within a sheep flock: 
  
• Clinical MVV disease develops slowly  
• 30% of infected animals develop clinical signs  
• The rate of transmission is influenced by flock 
prevalence and management factors  
• Host and viral genetics influence the extent of 
the disease  
• Concurrent disease will influence disease signs 
(Gonzalez et al., 1993) 





Table 1: Production effects and financial implications associated with MV infection within a flock. 
Physical Performance Baseline 
(disease free) 
Impact of Maedi 
Visna (at 20% 
prevalence based on 
ELISA seropositivity) 
  
Scanning rate - ewes (%) 200 200   
Scanning rate - ewe replacements (%) 160 160   
Empty rate - ewes (%)  4 8.4 Estimated 9% reduction in conception rates* 
Empty rate - ewe replacements (%) 7 7   
Total flock scanning rate (including 
empty) (%) 
182.9 174.5   
Stocking density (ewes/ ha) 10 10   
Total lamb mortality (scanning - sale) 
(%) 
12 13.2 Estimated 10% increase in lamb mortality* 
Rearing rate (%) 161.0 151.5   
Live weight (kg) 40 40   
Cull ewe value (£) 50.00 40.00 Estimated 20% reduction in cull ewe value due to 
chronic wasting*  
Replacement rate (%) 21 25.2 Estimated 20% increase in forced 
culling/replacement* 
Replacement female purchase cost (£) 120.00                        120.00    
Finishing rate (%) 140.0 126.3   
Killing out rate (%)  45 45   
Carcase weight (kg) 18 18   
Price per kilogram dead weight (£/kg 
dw) 
4.00                       3.95  Estimated 6% lower milk yield = 6% lower DLWG in 
20% of lambs suckling MV infected ewes = reduced 
mean market price achieved  





Variable Costs (£/kgdw) 2.84                                3.15   






Clinical Disease:  
 
Cases of MV may be difficult to identify due to the long incubation period of the disease; non-
specific clinical signs; and the susceptibility of infected sheep to concurrent diseases (Iratxe 
Leginagoikoa et al., 2006; Ritchie, Davies and Smith, 2012). Clinically infected sheep may present 
with one of two disease forms- ‘maedi’ or ‘visna’: both have been documented in the UK and are 
produced by infection with the same maedi visna virus (Ritchie, Davies and Smith, 2012).  
 
• Maedi:  
 
The more typical presentation within UK flocks is a chronic, progressive pneumonia in older sheep, 
typically over 3 years old (Winter and Clarkson, 2012). This interstitial pneumonia leads to a loss of 
condition, difficulty breathing and is eventually fatal (Winter and Clarkson, 2012). Post mortem 
examination of such affected sheep would show markedly enlarged and heavy lungs with a grey 
discolouration and obvious impression of the ribs (Minguijón et al., 2015) (Plate 1). Enlarged 
mediastinal lymph nodes are usually noted and MV cases are commonly associated with secondary 
bacterial infection, particularly pneumonic mannheimiosis. Concurrent cases of ovine pulmonary 
adenocarcinoma (OPA) have also been reported (Baird, 2010). 
 
• Visna:  
 
The neurological form of the disease is a slowly progressive disorder with weight loss in older sheep. 
This may progress from a unilateral conscious proprioceptive deficit in one hind limb to toe dragging 






• MV-related death and culling:  
 
Despite MVV targeting several organs, only the respiratory and neurological forms of the disease 
appear to lead to cachexia and death: viral strains targeting the mammary gland and joints may lead 
to premature culling due to poor performance (Minguijón et al., 2015). Mortality associated with 
small ruminant lentivirus (SRLV, Figure 1) infection is thought to be low in endemic areas, but is 
strongly influenced by concurrent disease, husbandry, nutrition and environmental factors 
(Peterhans et al., 2004). Such high rates of mortality in newly infected animals as documented 
during the Icelandic epidemic (Sigurdsson, Grímsson and Pálsson, 1952; Sigurdardóttir and Thormar, 
1964), have not been repeated: evidence suggests that the native Icelandic breed were highly 
susceptible to MVV infection. However whole flock culls due to poor performance associated with 
MVV infection have been documented in the UK (Priestley, 2016).  
 
 











Photo (above) showing two pairs of lungs from 3-year-old Texel 
rams. Unaffected lungs on the left (from a clinically well, 
MV negative ram) deflated on removal from the thoracic 
cavity and placement on the table reveals the heart. In 
comparison, the affected lungs (taken from an MV 
positive ram; right) failed to collapse when the chest was 
opened, have a firm-rubbery texture and are diffusely 
pale. The interstitial pneumonia in the MV animal causes 
the lungs to appear swollen, which obscures the heart in 
the photo.  
 
Photo (below) showing a lung infected with MV. On cut 
surface the parenchyma of the caudal lobe shows 




Gross post-mortem findings cannot 
be relied on for confirmation of MV. 
Further diagnostic tests are 
required:  
• Histology may be performed on 
formalin fixed samples of lung, 
bronchial lymph node, 
mammary gland, synovial 
membrane and brain.  
• Heart blood serum may be 
collected for serology.  
(Radostits et al., 2007).  
Photo source: Dr P. Davies, Pro Ovine Ltd.  





Sub-clinical Disease:  
 
• Ewe health and production:  
 
Many studies have identified production limiting affects in sub-clinically infected flocks. MVV 
infection is suggested to decrease the average lifespan of infected animals: they may be culled at 
least a year earlier due to reduced productivity (Peterhans et al., 2004).  
 
Infected ewes were found to have a reduction of 9% in conception rates compared to uninfected 
ewes and a 6% reduction in milk yield in dairy ewes of similar ages within the same flock (P. Davies, 
unpublished data collected from a flock of UK dairy ewes, based on cumulative milk yields; corrected 
days in milk; parity and serological MV diagnosis on milk ELISA.) Indurative mastitis may be found in 
infected ewes which inhibits the flow of milk throughout the mammary gland thus reducing milk 
yield (Snowder et al., 1990). Clinical examination of the udder may be unremarkable, and milk 
remains normal in appearance (Asadpour et al., 2014). High levels of bacterial and indurative 
mastitis have also been reported in clinically affected flocks in other studies (Pekelder et al., 1994; 
Ritchie, Davies and Smith, 2012). 
 
• Lamb performance:  
 
The effects of reduced milk yield due to MVV associated mastitis and induration on lamb production 
has not been accurately assessed within a UK setting. It is plausible that lambs nursing ewes with a 
high degree of induration and subsequent lower yield may lead to reduced survival and poor lamb 
growth. In other countries MV seropositivity has been associated with increased pre-weaning 
mortality (Arsenault et al., 2003). The effects of MV infection appear to be more marked with 





seropositive ewes were 3-6% lower than those born to non-infected ewes of the same age. The 
weaning weight of lambs born from seropositive ewes ≥ 4 years old was associated with a reduction 
of 0.94kg (Arsenault et al., 2003). These effects may be especially felt in medium or high prevalence 
UK flocks that aim to attain the higher sale prices associated with early lamb sales.  
 
How is MV transmitted? 
 
MV may be transmitted in a number of ways, although the chief route (vertical or horizontal) is 
unclear. MVV is spread via pulmonary secretions and milk containing infected macrophages, thus 
the respiratory route and the ingestion of infected milk and colostrum, known as lactogenic 
transmission, form the basis for natural MV transmission (Berriatua et al., 2003; Iratxe Leginagoikoa 
et al., 2006; Radostits et al., 2007). Successful eradication programmes focusing on the removal of 
lambs at birth and rearing on artificial milk and colostrum (Houwers et al., 1987), appear to 
demonstrate that in utero and intrapartum transmission are of little consequence (Cutlip, Lehmkuhl 
and Jackson, 1981). The virus can also be found in semen, saliva and urine (Houwers, 1990; Berriatua 
et al., 2003; Ritchie, Davies and Smith, 2012). 
 
The role of post-natal maternal transmission to offspring is of importance although the primary 
route of transmission (respiratory or lactogenic) remains unclear. The rate of transmission within a 
flock appears to be related to management procedures and MV flock prevalence. Although 
intensively farmed flocks appear to have higher prevalence (Iratxe Leginagoikoa et al., 2006) thus 
assuming transmission due to repeated close contact with infected sheep, studies have shown high 
rates of transmission in flocks with clinically healthy ewes with high MV prevalence, managed under 






The genetics surrounding the susceptibility of SRLV infection have been explored; some animals 
appear to be resistant despite repeated exposure to infection (Berriatua et al., 2003; I. Leginagoikoa 
et al., 2006; Heaton et al., 2012). Genetic selection for MVV resistance should be regarded 
cautiously: viral strains undergo frequent antigenic drift and so virus adaptation may diminish the 
benefit of previous genetic selection (Minguijón et al., 2015).  
 
It has been suggested that eradication programs, involving the removal of lambs at birth for artificial 
rearing, may fail due to poor hygiene and disinfection procedures (Houwers et al., 1987). Indeed, 
fomites are an important consideration during MV eradication even if survival outside the host is 
limited.  
 
Diagnosis of MVV Infection 
 
Although there is no universally accepted ‘gold standard’ to determine sensitivity and specificity of 
tests used for MV infection, successful control programs indicate that the tests available are useful in 
reducing prevalence of infection (Peterhans et al., 2004). Serological diagnosis used to detect MV 
antibody in infected animals is considered the most convenient diagnostic method. However, the 
time from infection to seroconversion can vary from a few weeks to several months (de la Concha-
Bermejillo, 1997; De Andrés et al., 2005). Repeated testing during diagnosis and eradication 
programmes are necessary (De Andrés et al., 2005) as animals with low antibody titres may become 
transiently seronegative despite latent infection (Houwers and Nauta, 1989), and it has been 
suggested that some carrier ewes may not test positive on the ELISA due to a disrupted immune 
response in some infected individuals (Gayo et al., 2017).  
 
The most commonly used laboratory techniques used in the UK for MV diagnosis are the agar gel 





specific but less sensitive than ELISA (Synge and Ritchie, 2010): it was found to be 76% sensitive and 
98% specific when compared to ELISA (De Andrés et al., 2005). Therefore, due to its high but 
subjective specificity and low sensitivity, the AGIDT is used mostly for confirmation of more sensitive 
ELISA results. 
 
ELISAs are suitable for screening large numbers of animals; are more sensitive than the AGIDT; and 
are quantitative allowing for computer-based analysis of raw data (Peterhans et al., 2004). 
Commercial ELISAs have been reported with a claimed sensitivity and specificity of 99.4% and 99.3%, 
respectively. However apparently high number of false positives have occurred when screening 
certain UK flocks, thus suggesting a lower specificity under some circumstances. To overcome this, 
the routine confirmatory testing of positives is recommended using alternative assays.   
 
Milk and bulk milk samples have been tested against SRLV for use and ease in dairy breeds 
(Minguijón et al., 2015). There is an agreement of 90% between ELISA used for blood and milk 
therefore milk samples may be preferable to serology in milking flocks and potentially meat flocks 
during lactation as they are easier and cheaper to obtain. MVV infection may also be identified from 
post mortem sampling (Plate 1). 
 
In summary it is vitally important to establish which tests are appropriate for the desired level of 
confidence and to select the appropriate type (Figure 3- see attached schematic) and number of 
animals to make flock screening valid and robust. Typically, this can be summarised as using a high-
sensitivity ELISA for screening followed by a high-specificity ELISA or AGIDT for any resulting positive 
samples generated. To establish flock status, i.e. for flock-screening tests, the highest risk sheep 
which are most likely to have antibodies should be selected, typically thin, older ewes who are more 







MVV Control Options 
 
Due to the long course of MVV infection control methods may span several years and so selecting 
the right plan is crucial to maximise compliance and plan success. MV control for an infected flock 
can either be via eradication or by conservative management. Many factors may influence the 
choice of plan including flock prevalence; farming production objectives; cost-benefit analysis; 
animal health and genetics (Minguijón et al., 2015). Analysis of flock production data may allow the 
effects of MV infection to be seen, for example assessing ewe longevity and lamb performance may 
address likely cost-benefit analysis of disease control. Flocks seeking full eradication must ensure 
that both vertical and horizontal routes of transmission are targeted (Minguijón et al., 2015). 
 
An overview of several control strategies has been provided by Minguijón et al. (2015): a flow 
diagram (Figure 4- see attached file) and several control strategies are outlined (Table 2).  
 
Table 2: Summary of MV Control Options 
Control Option Advantages Disadvantages 
1. Depopulation and repopulation  
 
Level of control: eradication 
 
The entire flock is culled and restocked with 
accredited or monitored MV free sheep.  
Works well for smaller 
flocks of low genetic 
value.  
 
Can quickly eliminate 
the disease if sufficient 
appropriate stock can 
be sourced  
Large financial 
implications associated 
with whole flock 
culling.  
 







Very successful method 
in Iceland (Pétursson, 
1994). 
Needs ready availability 
of disease-free stock 
for restocking 
2. Selective culling of infected animals 
+/- their progeny  
 
Level of control: eradication  
 
Repeated testing and culling of all stock >12 
months old. This method uses high sensitivity 
ELISA and AGIDT, outlined in Figure 3.  
 
All sheep on farm are routinely tested twice a 
year. Flocks frequently cull progeny (< 1 year 
old) of infected animals as well (Houwers et 
al., 1987; Williams-Fulton and Simard, 1989; 
Radostits et al., 2007).  
 
Replacements are sourced internally from 
seronegative mothers, ideally these should 
be older ewes which may be virus free and 
transmit resistant genes to their offspring 
(Berriatua et al., 2003; Radostits et al., 2007), 
May be useful in flocks 
with low to moderate 
prevalence; allows 
rapid reduction in 
seroprevalence (Reina 
et al., 2009). 
 
The diagnostic tests are 
sufficiently accurate to 
allow fairly rapid 
eradication.  
 
Culling progeny of 




(Reina et al., 2009). 
Flocks with high 
prevalence may see 
flock size reduce if 
culling is greater than 
the normal culling rate 
(Reina et al., 2009). 
 
Expensive in terms of 









or from MV-free monitored or accredited 
flocks.  
 
Eradication can be achieved in 1-3 cycles.  
3. Artificial rearing of lambs:  
 
Level of control: eradication 
 
• Lambs are snatched from their dams 
at birth; reared on bovine/ 
alternative milk and colostrum 
(Houwers et al., 1983; Williams-
Fulton and Simard, 1989); OR 
• Lambs are fostered onto MV-
accredited recipient ewes; OR 
• Embryo transfer (ET) into MV-
accredited recipient ewes.  
 
Lambs must be kept separate from the rest of 
the flock to prevent future horizontal disease 
transmission (Reina et al., 2009).  
 
On-going testing is necessary to ensure 
adequate hygiene measures are in place.    
May be used on a 
larger scale.  
 
If thorough hygiene 
procedures are 
adhered to, can be very 
effective.  
 
ET may be 
advantageous and 
economically viable in 





May be especially 
expensive if infected 
flock is not retained, 
though their continued 
presence poses a 
significant risk of 
horizontal transmission 
(Radostits et al., 2007). 
 
Lack of passive lamb 
immunity and artificial 








4. Separation of flock into two 
separate flocks 
 
Level of control: conservative  
 
The whole flock (>12 months old) is tested 
and separated according to infection status.  
The seronegative group must be kept isolated 
from the seropositive group and strict 
hygiene must be adhered to.  
 
Repeated testing continues on the 
seronegative group and any returning 
seropositive are immediately moved into the 
seropositive group.  
 
Replacements are sourced as of option 2.  
 
Works well for 
moderately/highly 
infected flock.   
 
Eliminates drastic 
culling procedures - 
keeps more stable flock 
numbers and may be 
more economically 
stable than culling 
positive animals/entire 
flock  (Reina et al., 
2009; Pérez et al., 
2013). 
Requires strict internal 
hygiene over 3-5 years, 
very difficult to 
maintain, especially 
around grazing and 
flock handling.  
 
Increased labour, large 
degree of planning.  
 
May have to increase 
farm facilities to 
maintain separate 
flocks - increased costs 
associated with this.  
5. Young flock, early culling: 
 
Level of control: conservative  
 
This method includes keeping a younger 
flock; increasing replacement rate and 
May reduce some 
effects of MV.  
The cost of keeping a 
younger flock with 
increasing culling and 
replacement rates may 
well outweigh the cost 





increase culling based on BCS and ewe 
performance.  
 
Flock may be kept in age stratified groups, 
and replacements kept from younger ewes.  
 
Replacements are bought in from MV-
accredited flocks and kept separate from 
older sheep.  
 
Batch testing of older and thin ewes is 
recommended.  
in the medium /long 
term. 
 
Horizontal and vertical 
transmission will 
continue, and 
subclinical disease will 
continue to cause 
production losses. 
 
Strict biosecurity procedures are necessary to ensure adequate control of MV infection or prevent 
re-infection in cases where eradication has been achieved. A single serological test may not be 
sufficient to determine the infection status of an individual animal due to differences in time to 
seroconversion (de la Concha-Bermejillo, 1997) and the immune response of infected individuals 
(Gayo et al., 2017). Therefore replacement ewes and rams should be sourced from MV-monitored or 
accredited flocks (Radostits et al., 2007) who have undergone multiple serological tests. As MVV has 
been found in the male genital system and viral shedding in semen has been shown, only certified 
MVV-free males should be used as semen donors for artificial insemination to avoid both horizontal 
and vertical transmission (Minguijón et al., 2015).  
 
Farmers selling MV seropositive stock must be strongly encouraged to sell either through the cull 
ewe market or direct to slaughter. Although there is the temptation to sell stock through other 






UK MV Accreditation:  
 
An MV accreditation scheme was introduced into Great Britain in 1982 and may be credited with 
limiting the spread of MV in the UK. The scheme parameters initially accredited participating flocks 
to have a MV prevalence of <2% with a confidence of 95%, tested on a biannual or triannual basis 
along with strict biosecurity precautions. Over 3000 flocks have participated in the scheme over the 
past 35 years.  
 
The high uptake of the scheme amongst pedigree producers may have had an important effect of 
limiting transmission within the national flock as these flocks have the greatest ‘contact’ with other, 
commercial flocks, primarily via the sale of breeding rams. Several hybrid breeds are also subject to 
similarly rigorous testing to prevent transmission to client flocks independently of the scheme. The 
current scheme now sets a standard of <5% prevalence and 95% confidence in order to achieve 
accreditation. This compares to the previous standard of <2% prevalence. It is important for owners 
to appreciate the fact that accreditation does not guarantee disease freedom!   
 
The uptake of the scheme has been minimal within the commercial lamb producing sector. Though 
the costs associated with testing may be high, the lack of clear cost benefits of disease freedom for 




Given that UK flock prevalence is rising and likely to accelerate, MV is destined to become a far more 
important problem for UK sheep industry. The effects may be increasingly felt within the lamb 





the turning point, or further research will underline how much MV is holding back the potential of 
UK sheep production. It is clear there is a need to engage a far larger proportion of flocks in disease 
screening and control if we are to avoid MV becoming a truly endemic disease in the UK as in 
countries such as Spain. Portugal or Canada where there are high numbers of infected flocks. 
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Figure 2: Factors influencing financial costs associated with MVV infection within a sheep flock: 
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Figure 3: Diagnostic options for MV investigation 
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Figure 4: Control strategies for MV infected flocks  
 
 
Authors biographies:  
 
Nicky Robinson:  
Graduated from Nottingham Vet School in 2013, since then she has worked in clinical farm practice 
in the Midlands and in New Zealand. She has completed a post-graduate certificate in Veterinary 
Medicine and Surgery, focusing on Iceberg Diseases in sheep. She returned to farm practice in Devon 
in summer 2018 and is currently working towards a Cert AVP.  
 





Dr Peers Davies graduated from Cambridge University Vet School in 2008. He worked in farm animal 
practice in Devon and North Wales. He founded Pro-Ovine Sheep Consultants in 2010 and was 
Clinical Lecturer in Sheep Health and Production from 2013-18. He is now Senior Lecturer in 
Livestock Health & Welfare at Liverpool University researching production limiting diseases of sheep.  
 
Fiona Lovatt 
Is a European and RCVS recognised specialist in Sheep Health and Production.  She runs the sheep 
veterinary consultancy business, Flock Health Ltd and is a clinical associate professor at the 






De Andrés, D. et al. (2005) ‘Diagnostic tests for small ruminant lentiviruses’, Veterinary Microbiology, 
107(1–2), pp. 49–62. doi: 10.1016/j.vetmic.2005.01.012. 
Arsenault, J. et al. (2003) ‘Maedi-visna impact on productivity in Quebec sheep flocks (Canada)’, 
Preventive Veterinary Medicine, 59(3), pp. 125–137. doi: 10.1016/S0167-5877(03)00086-2. 
Asadpour, R. et al. (2014) ‘Study on Correlation of Maedi-Visna Virus (MVV) with Ovine Subclinical 
Mastitis in Iran’, Indian Journal of Microbiology, 54(2), pp. 218–222. doi: 10.1007/s12088-013-0440-
x. 
Baird, G. (2010) ‘Maedi-Visna: stark reminder of accredited stock’s importance’, Veterinary Times, 
40(36), pp. 20–23. 
Berriatua, E. et al. (2003) ‘Transmission and control implications of seroconversion to Maedi-Visna 
virus in Basque dairy-sheep flocks’, Preventive Veterinary Medicine, 60(4), pp. 265–279. doi: 
10.1016/S0167-5877(03)00163-6. 
Cutlip, R. C., Lehmkuhl, H. D. and Jackson, T. A. (1981) ‘Intrauterine transmission of ovine progressive 
pneumonia virus.’, American Journal of Veterinary Research, 42(10), pp. 1795–1797. 
Dohoo, I. R. et al. (1987) ‘The Effetcs of Maedi-Visna Virus Infection on Productivity in Ewes’, 
Preventive Veterinary Medicine, 4, pp. 471–484. 
Gayo, E. et al. (2017) ‘Serological ELISA results are conditioned by individual immune response in 
ovine maedi visna’, Small Ruminant Research. Elsevier, 157(June), pp. 27–31. doi: 
10.1016/j.smallrumres.2017.10.008. 
Gonzalez, L. et al. (1993) ‘Pathological and epidemiological aspects of the coexistence of maedi-visna 
and sheep pulmonary adenomatosis’, Research in Veterinary Science, 54(2), pp. 140–146. doi: 
10.1016/0034-5288(93)90049-L. 
Heaton, M. P. et al. (2012) ‘Reduced lentivirus susceptibility in sheep with TMEM154 mutations’, 
PLoS Genetics. doi: 10.1371/journal.pgen.1002467. 





lambs’, Veterinary Microbiology, 8(2), pp. 179–185. doi: 10.1016/0378-1135(83)90064-0. 
Houwers, D. J. et al. (1987) ‘Maedi-visna control in sheep. III: Results and evaluation of a voluntary 
control program in The Netherlands over a period of four years.’, The Veterinary quarterly, 9 Suppl 
1(February), p. 29S–36S. doi: 10.1080/01652176.1987.9694136. 
Houwers, D. J. (1990) ‘Economic importance, epidemiology and control’, in Petursson, G. and Hoff-
Jorgensen, R. (eds) Maedi-visna and Related Diseases. Massachusetts: Kluwer Academic, pp. 83–117. 
de la Concha-Bermejillo, A. (1997) ‘Maedi-Visna and ovine progressive pneumonia’, Veterinary 
Clinics of North America-Food Animal Practice, 13(1), pp. 13–33. doi: 
http://dx.doi.org/10.1016/S0749-0720(15)30362-5. 
Leginagoikoa, I. et al. (2006) ‘Extensive rearing hinders Maedi-Visna Virus (MVV) infection in sheep’, 
Veterinary Research, 37(6), pp. 767–778. doi: 10.1051/vetres:2006034. 
Leginagoikoa, I. et al. (2006) ‘Horizontal Maedi-Visna virus (MVV) infection in adult dairy-sheep 
raised under varying MVV-infection pressures investigated by ELISA and PCR’, Research in Veterinary 
Science, 80(2), pp. 235–241. doi: 10.1016/j.rvsc.2005.05.003. 
Minguijón, E. et al. (2015) ‘Small ruminant lentivirus infections and diseases’, Veterinary 
Microbiology. Elsevier B.V., 181(1–2), pp. 75–89. doi: 10.1016/j.vetmic.2015.08.007. 
Nuotio, L. O. (2006) Control and eradication of viral diseases of ruminants. University of Helsinki, 
Helsinki, Finland. 
Pekelder, J. J. et al. (1994) ‘Ovine lentivirus induced indurative lymphocytic mastitis and its effect on 
the growth of lambs.’, The Veterinary record, 134(14), pp. 348–50. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/8017016. 
Pérez, M. et al. (2013) ‘Successful Visna/maedi control in a highly infected ovine dairy flock using 
serologic segregation and management strategies’, Preventive Veterinary Medicine, 112(3–4), pp. 
423–427. doi: 10.1016/j.prevetmed.2013.07.019. 
Peterhans, E. et al. (2004) ‘Routes of transmission and consequences of small ruminant lentiviruses 






Pétursson, G. (1994) ‘Experience with Visna Virus in Iceland’, Annals of the New York Academy of 
Sciences, 724(1), pp. 43–49. doi: 10.1111/j.1749-6632.1994.tb38894.x. 
Priestley, M. (2016) ‘How maedi visna led to whole flock cull’, Farmers Weekly. 
Radostits, O. . et al. (2007) Veterinary medicine. 10th edn. Philadelphia: Saunders Elsevier. 
Reina, R. et al. (2009) ‘Prevention strategies against small ruminant lentiviruses: An update’, The 
Veterinary Journal, 182(1), pp. 31–37. doi: 10.1016/j.tvjl.2008.05.008. 
Ritchie, C. M., Davies, I. H. and Smith, R. P. (2012) ‘Maedi Visna (MV) seroprevalence survey 2010’, 
pp. 1–17. Available at: http://beefandlamb.ahdb.org.uk/wp/wp-
content/uploads/2013/04/maedi_visna_final_report_sep_2012.pdf. 
Sigurdardóttir, B. and Thormar, H. (1964) ‘Isolation of a viral agent from the lungs of sheep affected 
with maedi’, Journal of Infectious Diseases, 114(1), pp. 55–60. doi: 10.1093/infdis/114.1.55. 
Sigurdsson, B., Grímsson, H. and Pálsson, P. (1952) ‘Maedi, a chronic, progressive infection of 
sheep’s lungs’, Journal of Infectious Diseases, 90(3), pp. 233–241. doi: 10.1093/infdis/90.3.233. 
Snowder, G. D. et al. (1990) ‘Analysis of milk production and composition in ewes seropositive and 
seronegative for ovine progressive pneumonia virus.’, SID Sheep Research Digest, 6(3), pp. 24–28. 
Williams-Fulton, N. R. and Simard, C. L. (1989) ‘Evaluation of two management procedures for the 
control of maedi-visna.’, Canadian journal of veterinary research = Revue canadienne de recherche 
veterinaire, 53(4), pp. 419–423. 
Winter, A. C. and Clarkson, M. J. (2012) A Handbook for the Sheep Clinician. 7th edn. CAB 
International 2012. 
 
